About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(tetO-CTGF)#Swu
transgene insertion, Shu Wu
MGI:5473718
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-CTGF)#Swu/0
involves: 129 * C57BL/6 * C57BL/6J MGI:5473719
cx2
Tg(SFTPC-rtTA)2Jaw/0
Tg(tetO-CTGF)#Swu/0
involves: 129 * C57BL/6 * C57BL/6J MGI:5473834


Genotype
MGI:5473719
cx1
Allelic
Composition
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-CTGF)#Swu/0
Genetic
Background
involves: 129 * C57BL/6 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Scgb1a1-rtTA)1Jaw mutation (3 available)
Tg(tetO-CTGF)#Swu mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• pups nursing on dams administered doxycycline from P1 to P14 exhibit decreased capillary formation in alveolar septa
• pups nursing on dams administered doxycycline from P1 to P14 exhibit disrupted alveolarization, showing a 27% and 31% decrease in the mean alveolar airspace area and mean cord length, respectively
• pups nursing on dams administered doxycycline from P1 to P14 exhibit disorganized elastic fiber deposition on alveolar surfaces and in septa
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 34% decrease in secondary septa
• marker analysis indicates that pups nursing on dams administered doxycycline from P1 to P14 exhibit increased myofibroblast differentiation in alveolar septa
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 48% increase in the proliferating cell index in alveolar septa
• pups nursing on dams administered doxycycline from P1 to P14 exhibit decreased capillary formation in alveolar septa
• pups nursing on dams administered doxycycline from P1 to P14 exhibit thickening in the peribronchial/peribronchiolar and perivascular regions of the lungs and increased collagen deposition in these regions, indicating fibrosis

cardiovascular system
• pups nursing on dams administered doxycycline from P1 to P14 exhibit decreased capillary formation in alveolar septa

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
lower respiratory tract disease DOID:0050161 J:171488




Genotype
MGI:5473834
cx2
Allelic
Composition
Tg(SFTPC-rtTA)2Jaw/0
Tg(tetO-CTGF)#Swu/0
Genetic
Background
involves: 129 * C57BL/6 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(SFTPC-rtTA)2Jaw mutation (1 available)
Tg(tetO-CTGF)#Swu mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 60% decrease of vWF+ intraacinous vessels in lungs at P14, indicating inhibition of pulmonary vascular development
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 70% increase in muscularization of pulmonary vessels, a 2-fold increase in medial wall thickness of vessels, and increased vessels with proliferating cells in the lungs, indicating pulmonary vascular remodeling
• pups nursing on dams administered doxycycline from P1 to P14 exhibit increased inflammatory cell infiltration in alveolar air spaces and perivascular regions of lungs, with a 9-fold increase in macrophage infiltration
• pups nursing on dams administered doxycycline from P1 to P14 exhibit an increase in macrophage and neutrophil counts and the presence of numerous multinucleated giant cells in bronchoalveolar lavage (BAL) fluids
• pups nursing on dams administered doxycycline from P1 to P14 exhibit larger and simplified alveoli with fewer secondary septa compared to controls at P7 and P14
• pups nursing on dams administered doxycycline from P1 to P14 show a 30% and 50% increase in mean linear intercept in lungs at P7 and P14, respectively and a 60% reduction in radial alveolar count at P14
• pups nursing on dams administered doxycycline from P1 to P14 exhibit simplified alveoli with fewer secondary septa compared to controls at P7 and P14

cardiovascular system
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 60% decrease of vWF+ intraacinous vessels in lungs at P14, indicating inhibition of pulmonary vascular development
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 70% increase in muscularization of pulmonary vessels, a 2-fold increase in medial wall thickness of vessels, and increased vessels with proliferating cells in the lungs, indicating pulmonary vascular remodeling
• pups nursing on dams administered doxycycline from P1 to P14 exhibit an increase in the ratio of right ventricle over left ventricle plus septum compared to controls, indicating hypertrophic right ventricles
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a higher right ventricular systolic pressure compared to controls
• pups nursing on dams administered doxycycline from P1 to P14 develop pulmonary hypertension as indicated by increased right ventricle systolic pressure and right ventricular hypertrophy

immune system
• pups nursing on dams administered doxycycline from P1 to P14 exhibit increased inflammatory cell infiltration in alveolar air spaces and perivascular regions of lungs, with a 9-fold increase in macrophage infiltration
• pups nursing on dams administered doxycycline from P1 to P14 exhibit an increase in macrophage and neutrophil counts and the presence of numerous multinucleated giant cells in bronchoalveolar lavage (BAL) fluids

muscle
• pups nursing on dams administered doxycycline from P1 to P14 exhibit an increase in the ratio of right ventricle over left ventricle plus septum compared to controls, indicating hypertrophic right ventricles

growth/size/body
• pups nursing on dams administered doxycycline from P1 to P14 exhibit an increase in the ratio of right ventricle over left ventricle plus septum compared to controls, indicating hypertrophic right ventricles

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
lower respiratory tract disease DOID:0050161 J:171151





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory